Skip to Main Content

Author Details

William C Reinhold
Center for Cancer Research, National Cancer Institute
1984
106
47
PMIDPaper TitleJournal TitlePublished Year
37140427CellMinerCDB: NCATS Is a Web-Based Portal Integrating Public Cancer Cell Line Databases for Pharmacogenomic Explorations.Cancer Res2023
37343696Proteomic Dynamics of Breast Cancer Cell Lines Identifies Potential Therapeutic Protein Targets.Mol Cell Proteomics2023
37140427CellMinerCDB: NCATS Is a Web-Based Portal Integrating Public Cancer Cell Line Databases for Pharmacogenomic Explorations.Cancer Res2023
37343696Proteomic Dynamics of Breast Cancer Cell Lines Identifies Potential Therapeutic Protein Targets.Mol Cell Proteomics2023
36325065Integrative epigenomic analyses of small cell lung cancer cells demonstrates the clinical translational relevance of gene body methylation.iScience2022
36325065Integrative epigenomic analyses of small cell lung cancer cells demonstrates the clinical translational relevance of gene body methylation.iScience2022
33196823CellMiner Cross-Database (CellMinerCDB) version 1.2: Exploration of patient-derived cancer cell line pharmacogenomics.Nucleic Acids Res2021
33676569Association of expression of epigenetic molecular factors with DNA methylation and sensitivity to chemotherapeutic agents in cancer cell lines.Clin Epigenetics2021
34050002R-Loop-Mediated ssDNA Breaks Accumulate Following Short-Term Exposure to the HDAC Inhibitor Romidepsin.Mol Cancer Res2021
33196823CellMiner Cross-Database (CellMinerCDB) version 1.2: Exploration of patient-derived cancer cell line pharmacogenomics.Nucleic Acids Res2021
33676569Association of expression of epigenetic molecular factors with DNA methylation and sensitivity to chemotherapeutic agents in cancer cell lines.Clin Epigenetics2021
34050002R-Loop-Mediated ssDNA Breaks Accumulate Following Short-Term Exposure to the HDAC Inhibitor Romidepsin.Mol Cancer Res2021
32586373Epigenome-wide DNA methylation analysis of small cell lung cancer cell lines suggests potential chemotherapy targets.Clin Epigenetics2020
32652468Candidate biomarker assessment for pharmacological response.Transl Oncol2020
32649884Epigenetic Regulation of DNA Repair Pathway Choice by MacroH2A1 Splice Variants Ensures Genome Stability.Mol Cell2020
32644137Association of Independent Prognostic Factors and Treatment Modality With Survival and Recurrence Outcomes in Breast Cancer.JAMA Netw Open2020
32586373Epigenome-wide DNA methylation analysis of small cell lung cancer cell lines suggests potential chemotherapy targets.Clin Epigenetics2020
33086069SCLC-CellMiner: A Resource for Small Cell Lung Cancer Cell Line Genomics and Pharmacology Based on Genomic Signatures.Cell Rep2020
33086069SCLC-CellMiner: A Resource for Small Cell Lung Cancer Cell Line Genomics and Pharmacology Based on Genomic Signatures.Cell Rep2020
32652468Candidate biomarker assessment for pharmacological response.Transl Oncol2020
32649884Epigenetic Regulation of DNA Repair Pathway Choice by MacroH2A1 Splice Variants Ensures Genome Stability.Mol Cell2020
32644137Association of Independent Prognostic Factors and Treatment Modality With Survival and Recurrence Outcomes in Breast Cancer.JAMA Netw Open2020
31113817RNA Sequencing of the NCI-60: Integration into CellMiner and CellMiner CDB.Cancer Res2019
31733513Quantitative Proteome Landscape of the NCI-60 Cancer Cell Lines.iScience2019
31113817RNA Sequencing of the NCI-60: Integration into CellMiner and CellMiner CDB.Cancer Res2019
31515286A novel assay to screen siRNA libraries identifies protein kinases required for chromosome transmission.Genome Res2019
31547492Tyrosyl-DNA Phosphodiesterase 1 and Topoisomerase I Activities as Predictive Indicators for Glioblastoma Susceptibility to Genotoxic Agents.Cancers (Basel)2019
31733513Quantitative Proteome Landscape of the NCI-60 Cancer Cell Lines.iScience2019
31547492Tyrosyl-DNA Phosphodiesterase 1 and Topoisomerase I Activities as Predictive Indicators for Glioblastoma Susceptibility to Genotoxic Agents.Cancers (Basel)2019
31515286A novel assay to screen siRNA libraries identifies protein kinases required for chromosome transmission.Genome Res2019
29426862Author Correction: Targeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemia.Nat Commun2018
29979591Macrophilones from the Marine Hydroid Macrorhynchia philippina Can Inhibit ERK Cascade Signaling.J Nat Prod2018
30553813CellMinerCDB for Integrative Cross-Database Genomics and Pharmacogenomics Analyses of Cancer Cell Lines.iScience2018
29719618ONC201 kills breast cancer cells <i>in vitro</i> by targeting mitochondria.Oncotarget2018
29426862Author Correction: Targeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemia.Nat Commun2018
29979591Macrophilones from the Marine Hydroid Macrorhynchia philippina Can Inhibit ERK Cascade Signaling.J Nat Prod2018
30553813CellMinerCDB for Integrative Cross-Database Genomics and Pharmacogenomics Analyses of Cancer Cell Lines.iScience2018
29719618ONC201 kills breast cancer cells <i>in vitro</i> by targeting mitochondria.Oncotarget2018
27601591Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer.Clin Cancer Res2017
28603778DNA-Targeted Precision Medicine; Have we Been Caught Sleeping?Trends Cancer2017
29235481Targeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemia.Nat Commun2017
27923837The NCI-60 Methylome and Its Integration into CellMiner.Cancer Res2017
27601591Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer.Clin Cancer Res2017
28158293Phosphorylated fraction of H2AX as a measurement for DNA damage in cancer cells and potential applications of a novel assay.PLoS One2017
28159862Temozolomide in the Era of Precision Medicine.Cancer Res2017
28159862Temozolomide in the Era of Precision Medicine.Cancer Res2017
28158293Phosphorylated fraction of H2AX as a measurement for DNA damage in cancer cells and potential applications of a novel assay.PLoS One2017
29235481Targeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemia.Nat Commun2017
28603778DNA-Targeted Precision Medicine; Have we Been Caught Sleeping?Trends Cancer2017
27923837The NCI-60 Methylome and Its Integration into CellMiner.Cancer Res2017
  • 1 - 50 of 212

Recommended Authors

Andrew Goodspeed
University of Colorado Denver | Anschutz Medical Campus
Career Start Year 2013
Number of shared co-authors 1
Frederick S Vizeacoumar
College of Medicine, University of Saskatchewan
Career Start Year 2010
Number of shared co-authors 0
Ritu Roy
University of California San Francisco.
Career Start Year 2007
Number of shared co-authors 3
Siyuan Zheng
Greehey Children's Cancer Research Institute
Career Start Year 2007
Number of shared co-authors 8
Pichai Raman
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year 2006
Number of shared co-authors 5
Raj Chari
The National Institutes of Health
Career Start Year 2006
Number of shared co-authors 7
Jesse S Boehm
Broad Institute of Harvard and MIT
Career Start Year 2004
Number of shared co-authors 8
Steffen Durinck
Genentech Inc.
Career Start Year 2004
Number of shared co-authors 8
Leslie Cope
Johns Hopkins University School of Medicine
Career Start Year 2003
Number of shared co-authors 1
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 0
Aik Choon Tan
Huntsman Cancer Institute, The University of Utah
Career Start Year 2003
Number of shared co-authors 1
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 11
Olivier Elemento
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 13
Michael Slifker
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 0
Yidong Chen
The University of Texas Health Science Center at San Antonio
Career Start Year 2001
Number of shared co-authors 3
Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year 2001
Number of shared co-authors 1
Liewei Wang
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 5
Paul T Spellman
Oregon Health & Science University Hospital.
Career Start Year 1998
Number of shared co-authors 20
Benedikt Brors
German Cancer Research Center (DKFZ)
Career Start Year 1997
Number of shared co-authors 10
Barbara A Weir
Janssen Research and Development LLC
Career Start Year 1997
Number of shared co-authors 8
Ultan McDermott
Wellcome Sanger Institute
Career Start Year 1993
Number of shared co-authors 14
Adam B Olshen
12224University of California san francisco
Career Start Year 1993
Number of shared co-authors 6
Arul M Chinnaiyan
University of Michigan Medical School.
Career Start Year 1993
Number of shared co-authors 6
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year 1992
Number of shared co-authors 19
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 2
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 5
Eivind Hovig
Center for Bioinformatics, University of Oslo
Career Start Year 1987
Number of shared co-authors 7
Jonathan R Pollack
Stanford University School of Medicine
Career Start Year 1987
Number of shared co-authors 3
Olli Kallioniemi
Karolinska Institute
Career Start Year 1984
Number of shared co-authors 18
Matthew Meyerson
Broad Institute
Career Start Year 1983
Number of shared co-authors 16

Collaborators

Yves Pommier
Center for Cancer Research, National Cancer Institute
Co-authored papers 56
John N Weinstein
The University of Texas MD Anderson Cancer Center
Co-authored papers 33
Sudhir Varma
Center for Cancer Research, National Cancer Institute
Co-authored papers 26
Kurt W Kohn
Center for Cancer Research, National Cancer Institute
Co-authored papers 15
Vinodh N Rajapakse
Co-authored papers 13
James H Doroshow
National Cancer Institute, National Institutes of Health
Co-authored papers 13
Augustin Luna
Harvard Medical School
Co-authored papers 11
Hongfang Liu
Mayo Clinic
Co-authored papers 11
Margot Sunshine
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 11
Barry R Zeeberg
Co-authored papers 10
Paul S Meltzer
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 9
Uwe Scherf
Co-authored papers 8
Satoshi Nishizuka
Co-authored papers 8
Uma Shankavaram
Co-authored papers 8
Samir Lababidi
Co-authored papers 8
Fathi Elloumi
Inc., Frederick National Laboratory for Cancer Research
Co-authored papers 8
Jae K Lee
Co-authored papers 7
Mirit I Aladjem
National Cancer Institute, Center for Cancer Research
Co-authored papers 7
Chris Sander
Broad Institute of MIT and Harvard
Co-authored papers 6
Mark Reimers
Institute for Quantitative Health Science and Engineering, Michigan State University
Co-authored papers 6
David W Kane
Co-authored papers 5
Fabricio G Sousa
Universidade Federal De Mato Grosso Do Sul
Co-authored papers 5
Vladimir Larionov
National Cancer Institute
Co-authored papers 5
Susan R Davis
Co-authored papers 5
Sean Davis
Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington
Co-authored papers 5
Dominic A Scudiero
Co-authored papers 5
Gabriele Zoppoli
University of Genoa and Ospedale Policlinico San Martino
Co-authored papers 4
Michael Ryan
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
Ari Kahn
Co-authored papers 4
Peter J Munson
and Blood Institute, National Institutes of Health
Co-authored papers 4
Release 1.2